The shares have spiked on the Buffet effect, but sales and profits are headed down, the outlook for recovery is uncertain and guidance looks far too optimistic. Valuations are not compelling.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.